SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '1rzg'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2YGN_A_ACTA1181_0 (WNT INHIBITORY FACTOR 1)	1rzg	FAB 412D LIGHT CHAIN (Homo sapiens)	3 / 3	TYR A 32 VAL A 2 THR A 28	None	0.89A	2ygnA-1rzgA: undetectable	2ygnA-1rzgA: 20.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3HUO_A_PNNA302_0 (CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE)	1rzg	FAB 412D LIGHT CHAIN (Homo sapiens)	4 / 6	LEU A 189 GLY A 190 ALA A 125 PRO A 126	None	0.43A	3huoA-1rzgA: undetectable	3huoA-1rzgA: 21.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JX3_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	1rzg	FAB 412D LIGHT CHAIN (Homo sapiens)	4 / 7	VAL A 111 ARG A 38 VAL A 18 PHE A 90	None SUC A9002 (-4.2A) None None	1.27A	3jx3A-1rzgA: undetectable 3jx3B-1rzgA: undetectable	3jx3A-1rzgA: 18.46 3jx3B-1rzgA: 18.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JX4_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	1rzg	FAB 412D LIGHT CHAIN (Homo sapiens)	4 / 6	VAL A 111 ARG A 38 VAL A 18 PHE A 90	None SUC A9002 (-4.2A) None None	1.34A	3jx4A-1rzgA: 0.0 3jx4B-1rzgA: 0.0	3jx4A-1rzgA: 18.46 3jx4B-1rzgA: 18.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3SU9_A_ACTA426_0 (UDP-N-ACETYLGLUCOSAM INE 1-CARBOXYVINYLTRANSF ERASE)	1rzg	FAB 412D LIGHT CHAIN (Homo sapiens)	3 / 3	GLN A 3 GLU A 1 LYS A 1	None	1.20A	3su9A-1rzgA: undetectable	3su9A-1rzgA: 21.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TIC_A_ZMRA1002_1 (NEURAMINIDASE)	1rzg	FAB 412D LIGHT CHAIN (Homo sapiens)	5 / 12	ARG A 83 GLU A 85 ASP A 86 GLU A 46 ARG A 62	None None None SUC A9002 (-2.9A) SUC A9002 (-4.2A)	1.46A	3ticA-1rzgA: undetectable	3ticA-1rzgA: 18.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TIC_B_ZMRB1002_1 (NEURAMINIDASE)	1rzg	FAB 412D LIGHT CHAIN (Homo sapiens)	5 / 12	ARG A 83 GLU A 85 ASP A 86 GLU A 46 ARG A 62	None None None SUC A9002 (-2.9A) SUC A9002 (-4.2A)	1.46A	3ticB-1rzgA: undetectable	3ticB-1rzgA: 18.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TIC_C_ZMRC1002_1 (NEURAMINIDASE)	1rzg	FAB 412D LIGHT CHAIN (Homo sapiens)	5 / 12	ARG A 83 GLU A 85 ASP A 86 GLU A 46 ARG A 62	None None None SUC A9002 (-2.9A) SUC A9002 (-4.2A)	1.46A	3ticC-1rzgA: undetectable	3ticC-1rzgA: 18.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TIC_D_ZMRD1002_1 (NEURAMINIDASE)	1rzg	FAB 412D LIGHT CHAIN (Homo sapiens)	5 / 12	ARG A 83 GLU A 85 ASP A 86 GLU A 46 ARG A 62	None None None SUC A9002 (-2.9A) SUC A9002 (-4.2A)	1.47A	3ticD-1rzgA: undetectable	3ticD-1rzgA: 18.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4B7Q_B_ZMRB601_1 (NEURAMINIDASE)	1rzg	FAB 412D LIGHT CHAIN (Homo sapiens)	5 / 12	ARG A 83 GLU A 85 ASP A 86 GLU A 46 ARG A 62	None None None SUC A9002 (-2.9A) SUC A9002 (-4.2A)	1.47A	4b7qB-1rzgA: undetectable	4b7qB-1rzgA: 18.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4CX4_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	1rzg	FAB 412D LIGHT CHAIN (Homo sapiens)	4 / 7	PHE A 90 VAL A 111 ARG A 38 VAL A 18	None None SUC A9002 (-4.2A) None	1.31A	4cx4A-1rzgA: undetectable 4cx4B-1rzgA: undetectable	4cx4A-1rzgA: 18.46 4cx4B-1rzgA: 18.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4CX7_A_H4BA600_1 (NITRIC OXIDE SYNTHASE, INDUCIBLE)	1rzg	FAB 412D LIGHT CHAIN (Homo sapiens)	4 / 8	SER A 68 ILE A 69 TRP A 36 GLU A 81	SUC A9001 ( 2.7A) None None None	1.28A	4cx7A-1rzgA: undetectable 4cx7B-1rzgA: undetectable	4cx7A-1rzgA: 20.89 4cx7B-1rzgA: 20.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4CX7_C_H4BC600_1 (NITRIC OXIDE SYNTHASE, INDUCIBLE)	1rzg	FAB 412D LIGHT CHAIN (Homo sapiens)	4 / 8	SER A 68 ILE A 69 TRP A 36 GLU A 81	SUC A9001 ( 2.7A) None None None	1.22A	4cx7C-1rzgA: undetectable 4cx7D-1rzgA: undetectable	4cx7C-1rzgA: 20.89 4cx7D-1rzgA: 20.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVN_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	1rzg	FAB 412D LIGHT CHAIN (Homo sapiens)	5 / 11	SER A 188 GLY A 134 THR A 135 ALA A 136 THR A 131	None	0.95A	4qvnH-1rzgA: undetectable 4qvnI-1rzgA: undetectable	4qvnH-1rzgA: 21.74 4qvnI-1rzgA: 23.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVN_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	1rzg	FAB 412D LIGHT CHAIN (Homo sapiens)	5 / 10	SER A 188 GLY A 134 THR A 135 ALA A 136 THR A 131	None	0.95A	4qvnV-1rzgA: undetectable 4qvnW-1rzgA: undetectable	4qvnV-1rzgA: 21.74 4qvnW-1rzgA: 23.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVP_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	1rzg	FAB 412D LIGHT CHAIN (Homo sapiens)	5 / 12	SER A 188 GLY A 134 THR A 135 ALA A 136 THR A 131	None	0.93A	4qvpH-1rzgA: undetectable 4qvpI-1rzgA: undetectable	4qvpH-1rzgA: 21.74 4qvpI-1rzgA: 23.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVP_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	1rzg	FAB 412D LIGHT CHAIN (Homo sapiens)	5 / 12	SER A 188 GLY A 134 THR A 135 ALA A 136 THR A 131	None	0.93A	4qvpV-1rzgA: undetectable 4qvpW-1rzgA: undetectable	4qvpV-1rzgA: 21.74 4qvpW-1rzgA: 23.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVQ_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	1rzg	FAB 412D LIGHT CHAIN (Homo sapiens)	5 / 11	SER A 188 GLY A 134 THR A 135 ALA A 136 THR A 131	None	0.95A	4qvqH-1rzgA: undetectable 4qvqI-1rzgA: undetectable	4qvqH-1rzgA: 21.74 4qvqI-1rzgA: 23.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVQ_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	1rzg	FAB 412D LIGHT CHAIN (Homo sapiens)	5 / 11	SER A 188 GLY A 134 THR A 135 ALA A 136 THR A 131	None	0.94A	4qvqV-1rzgA: undetectable 4qvqW-1rzgA: undetectable	4qvqV-1rzgA: 21.74 4qvqW-1rzgA: 23.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVV_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2)	1rzg	FAB 412D LIGHT CHAIN (Homo sapiens)	5 / 11	SER A 188 GLY A 134 THR A 135 ALA A 136 THR A 131	None	0.97A	4qvvH-1rzgA: undetectable	4qvvH-1rzgA: 21.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVV_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2)	1rzg	FAB 412D LIGHT CHAIN (Homo sapiens)	5 / 11	SER A 188 GLY A 134 THR A 135 ALA A 136 THR A 131	None	0.97A	4qvvV-1rzgA: undetectable	4qvvV-1rzgA: 21.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVY_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2)	1rzg	FAB 412D LIGHT CHAIN (Homo sapiens)	5 / 11	SER A 188 GLY A 134 THR A 135 ALA A 136 THR A 131	None	0.96A	4qvyH-1rzgA: undetectable	4qvyH-1rzgA: 21.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVY_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	1rzg	FAB 412D LIGHT CHAIN (Homo sapiens)	5 / 12	SER A 188 GLY A 134 THR A 135 ALA A 136 THR A 131	None	0.96A	4qvyV-1rzgA: undetectable 4qvyW-1rzgA: undetectable	4qvyV-1rzgA: 21.74 4qvyW-1rzgA: 23.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW0_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	1rzg	FAB 412D LIGHT CHAIN (Homo sapiens)	5 / 11	SER A 188 GLY A 134 THR A 135 ALA A 136 THR A 131	None	0.96A	4qw0H-1rzgA: undetectable 4qw0I-1rzgA: undetectable	4qw0H-1rzgA: 21.74 4qw0I-1rzgA: 23.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW0_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	1rzg	FAB 412D LIGHT CHAIN (Homo sapiens)	5 / 11	SER A 188 GLY A 134 THR A 135 ALA A 136 THR A 131	None	0.96A	4qw0V-1rzgA: undetectable 4qw0W-1rzgA: undetectable	4qw0V-1rzgA: 21.74 4qw0W-1rzgA: 23.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW1_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	1rzg	FAB 412D LIGHT CHAIN (Homo sapiens)	5 / 12	SER A 188 GLY A 134 THR A 135 ALA A 136 THR A 131	None	0.96A	4qw1H-1rzgA: undetectable 4qw1I-1rzgA: undetectable	4qw1H-1rzgA: 21.74 4qw1I-1rzgA: 23.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW1_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	1rzg	FAB 412D LIGHT CHAIN (Homo sapiens)	5 / 12	SER A 188 GLY A 134 THR A 135 ALA A 136 THR A 131	None	0.96A	4qw1V-1rzgA: undetectable 4qw1W-1rzgA: undetectable	4qw1V-1rzgA: 21.74 4qw1W-1rzgA: 23.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QWU_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	1rzg	FAB 412D LIGHT CHAIN (Homo sapiens)	5 / 11	SER A 188 GLY A 134 THR A 135 ALA A 136 THR A 131	None	0.95A	4qwuH-1rzgA: undetectable 4qwuI-1rzgA: 0.0	4qwuH-1rzgA: 21.74 4qwuI-1rzgA: 23.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QWU_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	1rzg	FAB 412D LIGHT CHAIN (Homo sapiens)	5 / 11	SER A 188 GLY A 134 THR A 135 ALA A 136 THR A 131	None	0.96A	4qwuV-1rzgA: undetectable 4qwuW-1rzgA: undetectable	4qwuV-1rzgA: 21.74 4qwuW-1rzgA: 23.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ADD_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	1rzg	FAB 412D LIGHT CHAIN (Homo sapiens)	4 / 6	VAL A 111 ARG A 38 VAL A 18 PHE A 90	None SUC A9002 (-4.2A) None None	1.28A	5addA-1rzgA: 0.0 5addB-1rzgA: 0.0	5addA-1rzgA: 18.46 5addB-1rzgA: 18.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ADE_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	1rzg	FAB 412D LIGHT CHAIN (Homo sapiens)	4 / 6	VAL A 111 ARG A 38 VAL A 18 PHE A 90	None SUC A9002 (-4.2A) None None	1.32A	5adeA-1rzgA: 0.0 5adeB-1rzgA: 0.0	5adeA-1rzgA: 18.46 5adeB-1rzgA: 18.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5BXN_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	1rzg	FAB 412D LIGHT CHAIN (Homo sapiens)	5 / 11	SER A 188 GLY A 134 THR A 135 ALA A 136 THR A 131	None	0.96A	5bxnH-1rzgA: undetectable 5bxnI-1rzgA: undetectable	5bxnH-1rzgA: 21.69 5bxnI-1rzgA: 23.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5CZ7_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	1rzg	FAB 412D LIGHT CHAIN (Homo sapiens)	5 / 12	SER A 188 GLY A 134 THR A 135 ALA A 136 THR A 131	None	0.96A	5cz7V-1rzgA: undetectable 5cz7W-1rzgA: undetectable	5cz7V-1rzgA: 21.74 5cz7W-1rzgA: 23.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5D0X_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2)	1rzg	FAB 412D LIGHT CHAIN (Homo sapiens)	5 / 11	SER A 188 GLY A 134 THR A 135 ALA A 136 THR A 131	None	0.95A	5d0xV-1rzgA: undetectable	5d0xV-1rzgA: 21.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L5F_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	1rzg	FAB 412D LIGHT CHAIN (Homo sapiens)	5 / 12	SER A 188 GLY A 134 THR A 135 ALA A 136 THR A 131	None	0.92A	5l5fH-1rzgA: undetectable 5l5fI-1rzgA: undetectable	5l5fH-1rzgA: 21.74 5l5fI-1rzgA: 23.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L5F_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	1rzg	FAB 412D LIGHT CHAIN (Homo sapiens)	5 / 12	SER A 188 GLY A 134 THR A 135 ALA A 136 THR A 131	None	0.92A	5l5fV-1rzgA: undetectable 5l5fW-1rzgA: undetectable	5l5fV-1rzgA: 21.74 5l5fW-1rzgA: 23.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L66_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	1rzg	FAB 412D LIGHT CHAIN (Homo sapiens)	5 / 12	SER A 188 GLY A 134 THR A 135 ALA A 136 THR A 131	None	0.95A	5l66H-1rzgA: undetectable 5l66I-1rzgA: undetectable	5l66H-1rzgA: 21.74 5l66I-1rzgA: 23.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L66_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	1rzg	FAB 412D LIGHT CHAIN (Homo sapiens)	5 / 12	SER A 188 GLY A 134 THR A 135 ALA A 136 THR A 131	None	0.95A	5l66V-1rzgA: undetectable 5l66W-1rzgA: undetectable	5l66V-1rzgA: 21.74 5l66W-1rzgA: 23.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6HWD_H_BO2H301_0 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	1rzg	FAB 412D LIGHT CHAIN (Homo sapiens)	5 / 12	SER A 188 GLY A 134 THR A 135 ALA A 136 THR A 131	None	1.05A	6hwdH-1rzgA: undetectable 6hwdI-1rzgA: undetectable	6hwdH-1rzgA: 19.90 6hwdI-1rzgA: 15.15

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["2YGN_A_ACTA1181_0","WNT INHIBITORY FACTOR 1","1rzg","FAB 412D LIGHT CHAIN","Homo sapiens",3,"TYR A  32;VAL A   2;THR A  28","None","0.89A","2ygnA-1rzgA:undetectable","2ygnA-1rzgA:20.82"],["3HUO_A_PNNA302_0","CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE","1rzg","FAB 412D LIGHT CHAIN","Homo sapiens",4,"LEU A 189;GLY A 190;ALA A 125;PRO A 126","None","0.43A","3huoA-1rzgA:undetectable","3huoA-1rzgA:21.45"],["3JX3_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","1rzg","FAB 412D LIGHT CHAIN","Homo sapiens",4,"VAL A 111;ARG A  38;VAL A  18;PHE A  90","None;SUC A9002 (-4.2A);None;None","1.27A","3jx3A-1rzgA:undetectable;3jx3B-1rzgA:undetectable","3jx3A-1rzgA:18.46;3jx3B-1rzgA:18.46"],["3JX4_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","1rzg","FAB 412D LIGHT CHAIN","Homo sapiens",4,"VAL A 111;ARG A  38;VAL A  18;PHE A  90","None;SUC A9002 (-4.2A);None;None","1.34A","3jx4A-1rzgA:0.0;3jx4B-1rzgA:0.0","3jx4A-1rzgA:18.46;3jx4B-1rzgA:18.46"],["3SU9_A_ACTA426_0","UDP-N-ACETYLGLUCOSAMINE 1-CARBOXYVINYLTRANSFERASE","1rzg","FAB 412D LIGHT CHAIN","Homo sapiens",3,"GLN A   3;GLU A   1;LYS A   1","None","1.20A","3su9A-1rzgA:undetectable","3su9A-1rzgA:21.17"],["3TIC_A_ZMRA1002_1","NEURAMINIDASE","1rzg","FAB 412D LIGHT CHAIN","Homo sapiens",5,"ARG A  83;GLU A  85;ASP A  86;GLU A  46;ARG A  62","None;None;None;SUC A9002 (-2.9A);SUC A9002 (-4.2A)","1.46A","3ticA-1rzgA:undetectable","3ticA-1rzgA:18.76"],["3TIC_B_ZMRB1002_1","NEURAMINIDASE","1rzg","FAB 412D LIGHT CHAIN","Homo sapiens",5,"ARG A  83;GLU A  85;ASP A  86;GLU A  46;ARG A  62","None;None;None;SUC A9002 (-2.9A);SUC A9002 (-4.2A)","1.46A","3ticB-1rzgA:undetectable","3ticB-1rzgA:18.76"],["3TIC_C_ZMRC1002_1","NEURAMINIDASE","1rzg","FAB 412D LIGHT CHAIN","Homo sapiens",5,"ARG A  83;GLU A  85;ASP A  86;GLU A  46;ARG A  62","None;None;None;SUC A9002 (-2.9A);SUC A9002 (-4.2A)","1.46A","3ticC-1rzgA:undetectable","3ticC-1rzgA:18.76"],["3TIC_D_ZMRD1002_1","NEURAMINIDASE","1rzg","FAB 412D LIGHT CHAIN","Homo sapiens",5,"ARG A  83;GLU A  85;ASP A  86;GLU A  46;ARG A  62","None;None;None;SUC A9002 (-2.9A);SUC A9002 (-4.2A)","1.47A","3ticD-1rzgA:undetectable","3ticD-1rzgA:18.76"],["4B7Q_B_ZMRB601_1","NEURAMINIDASE","1rzg","FAB 412D LIGHT CHAIN","Homo sapiens",5,"ARG A  83;GLU A  85;ASP A  86;GLU A  46;ARG A  62","None;None;None;SUC A9002 (-2.9A);SUC A9002 (-4.2A)","1.47A","4b7qB-1rzgA:undetectable","4b7qB-1rzgA:18.24"],["4CX4_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","1rzg","FAB 412D LIGHT CHAIN","Homo sapiens",4,"PHE A  90;VAL A 111;ARG A  38;VAL A  18","None;None;SUC A9002 (-4.2A);None","1.31A","4cx4A-1rzgA:undetectable;4cx4B-1rzgA:undetectable","4cx4A-1rzgA:18.46;4cx4B-1rzgA:18.46"],["4CX7_A_H4BA600_1","NITRIC OXIDE SYNTHASE, INDUCIBLE;NITRIC OXIDE SYNTHASE, INDUCIBLE","1rzg","FAB 412D LIGHT CHAIN","Homo sapiens",4,"SER A  68;ILE A  69;TRP A  36;GLU A  81","SUC A9001 ( 2.7A);None;None;None","1.28A","4cx7A-1rzgA:undetectable;4cx7B-1rzgA:undetectable","4cx7A-1rzgA:20.89;4cx7B-1rzgA:20.89"],["4CX7_C_H4BC600_1","NITRIC OXIDE SYNTHASE, INDUCIBLE;NITRIC OXIDE SYNTHASE, INDUCIBLE","1rzg","FAB 412D LIGHT CHAIN","Homo sapiens",4,"SER A  68;ILE A  69;TRP A  36;GLU A  81","SUC A9001 ( 2.7A);None;None;None","1.22A","4cx7C-1rzgA:undetectable;4cx7D-1rzgA:undetectable","4cx7C-1rzgA:20.89;4cx7D-1rzgA:20.89"],["4QVN_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","1rzg","FAB 412D LIGHT CHAIN","Homo sapiens",5,"SER A 188;GLY A 134;THR A 135;ALA A 136;THR A 131","None","0.95A","4qvnH-1rzgA:undetectable;4qvnI-1rzgA:undetectable","4qvnH-1rzgA:21.74;4qvnI-1rzgA:23.17"],["4QVN_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","1rzg","FAB 412D LIGHT CHAIN","Homo sapiens",5,"SER A 188;GLY A 134;THR A 135;ALA A 136;THR A 131","None","0.95A","4qvnV-1rzgA:undetectable;4qvnW-1rzgA:undetectable","4qvnV-1rzgA:21.74;4qvnW-1rzgA:23.17"],["4QVP_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","1rzg","FAB 412D LIGHT CHAIN","Homo sapiens",5,"SER A 188;GLY A 134;THR A 135;ALA A 136;THR A 131","None","0.93A","4qvpH-1rzgA:undetectable;4qvpI-1rzgA:undetectable","4qvpH-1rzgA:21.74;4qvpI-1rzgA:23.17"],["4QVP_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","1rzg","FAB 412D LIGHT CHAIN","Homo sapiens",5,"SER A 188;GLY A 134;THR A 135;ALA A 136;THR A 131","None","0.93A","4qvpV-1rzgA:undetectable;4qvpW-1rzgA:undetectable","4qvpV-1rzgA:21.74;4qvpW-1rzgA:23.17"],["4QVQ_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","1rzg","FAB 412D LIGHT CHAIN","Homo sapiens",5,"SER A 188;GLY A 134;THR A 135;ALA A 136;THR A 131","None","0.95A","4qvqH-1rzgA:undetectable;4qvqI-1rzgA:undetectable","4qvqH-1rzgA:21.74;4qvqI-1rzgA:23.17"],["4QVQ_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","1rzg","FAB 412D LIGHT CHAIN","Homo sapiens",5,"SER A 188;GLY A 134;THR A 135;ALA A 136;THR A 131","None","0.94A","4qvqV-1rzgA:undetectable;4qvqW-1rzgA:undetectable","4qvqV-1rzgA:21.74;4qvqW-1rzgA:23.17"],["4QVV_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2","1rzg","FAB 412D LIGHT CHAIN","Homo sapiens",5,"SER A 188;GLY A 134;THR A 135;ALA A 136;THR A 131","None","0.97A","4qvvH-1rzgA:undetectable","4qvvH-1rzgA:21.74"],["4QVV_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2","1rzg","FAB 412D LIGHT CHAIN","Homo sapiens",5,"SER A 188;GLY A 134;THR A 135;ALA A 136;THR A 131","None","0.97A","4qvvV-1rzgA:undetectable","4qvvV-1rzgA:21.74"],["4QVY_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2","1rzg","FAB 412D LIGHT CHAIN","Homo sapiens",5,"SER A 188;GLY A 134;THR A 135;ALA A 136;THR A 131","None","0.96A","4qvyH-1rzgA:undetectable","4qvyH-1rzgA:21.74"],["4QVY_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","1rzg","FAB 412D LIGHT CHAIN","Homo sapiens",5,"SER A 188;GLY A 134;THR A 135;ALA A 136;THR A 131","None","0.96A","4qvyV-1rzgA:undetectable;4qvyW-1rzgA:undetectable","4qvyV-1rzgA:21.74;4qvyW-1rzgA:23.17"],["4QW0_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","1rzg","FAB 412D LIGHT CHAIN","Homo sapiens",5,"SER A 188;GLY A 134;THR A 135;ALA A 136;THR A 131","None","0.96A","4qw0H-1rzgA:undetectable;4qw0I-1rzgA:undetectable","4qw0H-1rzgA:21.74;4qw0I-1rzgA:23.17"],["4QW0_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","1rzg","FAB 412D LIGHT CHAIN","Homo sapiens",5,"SER A 188;GLY A 134;THR A 135;ALA A 136;THR A 131","None","0.96A","4qw0V-1rzgA:undetectable;4qw0W-1rzgA:undetectable","4qw0V-1rzgA:21.74;4qw0W-1rzgA:23.17"],["4QW1_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","1rzg","FAB 412D LIGHT CHAIN","Homo sapiens",5,"SER A 188;GLY A 134;THR A 135;ALA A 136;THR A 131","None","0.96A","4qw1H-1rzgA:undetectable;4qw1I-1rzgA:undetectable","4qw1H-1rzgA:21.74;4qw1I-1rzgA:23.17"],["4QW1_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","1rzg","FAB 412D LIGHT CHAIN","Homo sapiens",5,"SER A 188;GLY A 134;THR A 135;ALA A 136;THR A 131","None","0.96A","4qw1V-1rzgA:undetectable;4qw1W-1rzgA:undetectable","4qw1V-1rzgA:21.74;4qw1W-1rzgA:23.17"],["4QWU_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","1rzg","FAB 412D LIGHT CHAIN","Homo sapiens",5,"SER A 188;GLY A 134;THR A 135;ALA A 136;THR A 131","None","0.95A","4qwuH-1rzgA:undetectable;4qwuI-1rzgA:0.0","4qwuH-1rzgA:21.74;4qwuI-1rzgA:23.17"],["4QWU_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","1rzg","FAB 412D LIGHT CHAIN","Homo sapiens",5,"SER A 188;GLY A 134;THR A 135;ALA A 136;THR A 131","None","0.96A","4qwuV-1rzgA:undetectable;4qwuW-1rzgA:undetectable","4qwuV-1rzgA:21.74;4qwuW-1rzgA:23.17"],["5ADD_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","1rzg","FAB 412D LIGHT CHAIN","Homo sapiens",4,"VAL A 111;ARG A  38;VAL A  18;PHE A  90","None;SUC A9002 (-4.2A);None;None","1.28A","5addA-1rzgA:0.0;5addB-1rzgA:0.0","5addA-1rzgA:18.46;5addB-1rzgA:18.46"],["5ADE_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","1rzg","FAB 412D LIGHT CHAIN","Homo sapiens",4,"VAL A 111;ARG A  38;VAL A  18;PHE A  90","None;SUC A9002 (-4.2A);None;None","1.32A","5adeA-1rzgA:0.0;5adeB-1rzgA:0.0","5adeA-1rzgA:18.46;5adeB-1rzgA:18.46"],["5BXN_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","1rzg","FAB 412D LIGHT CHAIN","Homo sapiens",5,"SER A 188;GLY A 134;THR A 135;ALA A 136;THR A 131","None","0.96A","5bxnH-1rzgA:undetectable;5bxnI-1rzgA:undetectable","5bxnH-1rzgA:21.69;5bxnI-1rzgA:23.17"],["5CZ7_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","1rzg","FAB 412D LIGHT CHAIN","Homo sapiens",5,"SER A 188;GLY A 134;THR A 135;ALA A 136;THR A 131","None","0.96A","5cz7V-1rzgA:undetectable;5cz7W-1rzgA:undetectable","5cz7V-1rzgA:21.74;5cz7W-1rzgA:23.17"],["5D0X_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2","1rzg","FAB 412D LIGHT CHAIN","Homo sapiens",5,"SER A 188;GLY A 134;THR A 135;ALA A 136;THR A 131","None","0.95A","5d0xV-1rzgA:undetectable","5d0xV-1rzgA:21.74"],["5L5F_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","1rzg","FAB 412D LIGHT CHAIN","Homo sapiens",5,"SER A 188;GLY A 134;THR A 135;ALA A 136;THR A 131","None","0.92A","5l5fH-1rzgA:undetectable;5l5fI-1rzgA:undetectable","5l5fH-1rzgA:21.74;5l5fI-1rzgA:23.17"],["5L5F_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","1rzg","FAB 412D LIGHT CHAIN","Homo sapiens",5,"SER A 188;GLY A 134;THR A 135;ALA A 136;THR A 131","None","0.92A","5l5fV-1rzgA:undetectable;5l5fW-1rzgA:undetectable","5l5fV-1rzgA:21.74;5l5fW-1rzgA:23.17"],["5L66_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","1rzg","FAB 412D LIGHT CHAIN","Homo sapiens",5,"SER A 188;GLY A 134;THR A 135;ALA A 136;THR A 131","None","0.95A","5l66H-1rzgA:undetectable;5l66I-1rzgA:undetectable","5l66H-1rzgA:21.74;5l66I-1rzgA:23.17"],["5L66_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","1rzg","FAB 412D LIGHT CHAIN","Homo sapiens",5,"SER A 188;GLY A 134;THR A 135;ALA A 136;THR A 131","None","0.95A","5l66V-1rzgA:undetectable;5l66W-1rzgA:undetectable","5l66V-1rzgA:21.74;5l66W-1rzgA:23.17"],["6HWD_H_BO2H301_0","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","1rzg","FAB 412D LIGHT CHAIN","Homo sapiens",5,"SER A 188;GLY A 134;THR A 135;ALA A 136;THR A 131","None","1.05A","6hwdH-1rzgA:undetectable;6hwdI-1rzgA:undetectable","6hwdH-1rzgA:19.90;6hwdI-1rzgA:15.15"]]